Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Marler Clark, Hawai’i Woman Sue Supplement Manufacturer and Retailer Over Liver Injury
  • USA - English


News provided by

Marler Clark LLP, PS

Nov 20, 2013, 15:00 ET

Share this article

Share toX

Share this article

Share toX

Makers of OxyElite Pro Sued in Hawai'i
Makers of OxyElite Pro Sued in Hawai'i

We are alleging that OxyElite Pro was unsafe for human consumption and are asking the Court for just compensation for my client's injuries. - Attorney Bruce Clark

Post this

Honolulu, HI (PRWEB) November 20, 2013 -- A lawsuit was filed Tuesday in U.S. District Court for the District of Hawaii (Case No. CV 13-00635LEK-KSC) against USPlabs LLC and GNC Holdings, Inc., the manufacturer and retailer who sold OxyElite Pro, a synthetic dietary supplement that public health officials have determined is the source of an outbreak of acute liver failure and hepatitis among residents of Hawai’i.[1] The lawsuit was filed by Seattle-based Marler Clark, the nation’s leading law firm representing victims of foodborne illness, and Michael F. O’Connor of Honolulu-based Ogawa, Lau, Nakamura & Jew.

According to the complaint, OxyElite Pro is marketed and sold by USPlabs LLC as a beneficial dietary supplement for muscle increase and weight loss. The U.S. Food and Drug Administration previously found the supplement to contain Ageline, a synthetic version of a natural extract from the Bael tree. Aegeline has not been proven to be safe and has not been approved by the FDA for inclusion in dietary supplements.[1] The OxyElite Pro product was sold at GNC retail locations in Hawaii.

According to the complaint, the Hawai’i Department of Health was notified on September 9, 2013 that doctors were treating 7 patients with severe acute hepatitis and liver failure who shared a history of consuming OxyElite Pro. In an October 8 press release, the health department, following its investigation into those cases of liver failure and acute hepatitis, requested that retailers remove OxyElite Pro from store shelves.[2] By November 9, USPlabs recalled numerous lots and sizes of various formulations of OxyElite Pro dietary supplements due to epidemiologic evidence showing that the use of the products was associated with adverse health consequences.[1] Following the announcement, on November 19, the Hololulu Star-Advertiser reported that health officials were planning to destroy over $250,000 worth of OxyELITE Pro products.[3]

According to the complaint, plaintiff Everine Van Houten, a Hawai’i County resident, alleges that she purchased two containers of OxyElite Pro from the GNC store located in the Prince Kuhio Plaza in Hilo, Hawai’i in March of 2013. Court documents state that she also received two sample-sized containers of a “new” formulation of OxyElite Pro as part of her purchase. The lawsuit alleges that Ms. Van Houten consumed both the regular OxyElite Pro tablets and the “new” formulation of OxyElite Pro over the next several months and that she was treated for symptoms of abdominal pain, nausea, fatigue and muscle aches on numerous occasions at Hilo Medical Center during that timeframe. The lawsuit alleges that Ms. Van Houten underwent multiple tests and medical procedures to determine the nature and extent of her liver illness before she saw a September, 2013 public health notice advising of a possible link between cases of acute hepatitis and OxyElite Pro products. Court documents further state that Ms.Van Houten’s liver illness was caused by her consumption of the OxyElite Pro product.

Attorney Bruce Clark stated: “We are alleging in this lawsuit that OxyElite Pro was unsafe for human consumption and are asking the Court for just compensation for my client's injuries.”

According to the complaint, Ms. Van Houten was unable to work through much of 2013 due to her acute hepatitis and related symptoms and medical care. Court documents state that she continues to undergo testing and medical monitoring of her liver and continues to experience symptoms related to her liver injury.

BACKGROUND: Marler Clark has represented thousands of victims of E. coli and other foodborne illness outbreaks since the 1993 Jack in the Box E. coli outbreak (Pierce County Superior Court Case No. 93-2-00930-1). The law firm has recovered over $600 million for victims of food-related outbreaks.

1. OxyElite Pro Supplements Recalled. U.S. Food and Drug Administration. Last Updated Nov. 18, 2013.

2. See "Department of Health Requests Voluntary Removal of Oxyelite Pro Supplement from Sale." Hawai'i Department of Health. October 8, 2013.

3. See "Dodgy dietary supplement is headed to the incinerator" Sarah Zoellick, Honolulu Star Advertiser. November 19, 2013.

Suzanne Schreck, Marler Clark LLP, PS, http://www.marlerclark.com, +1 2063461878, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.